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Abstract 
Cigarette smoking is a major public health problem that is associated with high morbidity and 
mortality. This study was designed to investigate the relationship between cigarette smoking 
and concentration of testosterone in the urine. Forty young men age between 23 to 31 years 
were used for this study. The subjects were divided into two groups of 20 controls (non-
cigarette smoker) and 20 experimental groups (cigarette smoker). 5ml of mid-stream urine 
was collected from each subject at 0700 hour and urine testosterone concentration was 
estimated using enzyme immunoassay method. The result showed that the urinary 
testosterone concentration of non-cigarette smokers was 4.35±0.52 ng/ml, while the 
concentration in cigarette smokers was 2.81±0.38 ng/ml with p<0.01. It is concluded that 
cigarette smoking reduced urinary testosterone concentration among cigarette smokers. 
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Cigarette smoking is a major public health 
problem. Each year, tobacco is responsible for 
the deaths of about 3.5 million people. These 
numbers of deaths are increasing, and unless 
current trends of deaths are reversed, by the 
decade 2020-2030, it is estimated that tobacco 
will kill 10 million people a year with 70% of 
these deaths occurring in developing 
countries.
1
 Cigarette smoking epidemic is at an 
earlier stage in Africa, Asia, South America 
and certain areas of Southern Europe where 
smoking is found predominantly among men
2
. 
A survey conducted in Nigeria showed that 
24.4% of males and 6.7% of females smoked 




In male, cigarette smoking is associated with a 
decreased testosterone (a hormone which 
increases sexual urge) level, destruction of 
sperms, decreased sperm motility, relative 
infertility and impotence. Shrinkage of male 
genitalia was reported but insufficient to 
constitute a real deterrent to smoking4. 
 
It was found that nicotine (the main bioactive 
biochemical substance in tobacco) inhibited 
steroidogenesis in mouse Leydig cells5. The 
chronic treatment with nicotine has been 
reported to cause decrease in fertilization 
ability in male animals6. It has also been found 
out that nicotine inhibits pulsatile luteinizing 
hormone (LH) secretion in males
7
. Cigarette 
smoking and intravenous nicotine infusion has 





This study was undertaken to find the 
relationship between cigarette smoking and 
urinary testosterone secretion among cigarette 
smokers in Ilorin. 
 
MATERIALS AND METHODS 
 
Forty men were recruited for this study at 
Tanke area of Ilorin. They were provided with 
written informed consent for participation in 
the study.  All the men selected for the study 
were in good physical health as certified by 
physician at the university health centre. These 
subjects did not differ significantly with 
respect to age and body mass index. The 
characteristics of subjects are summarized in 
table 1.  














Samples Collection and Procedures 
5ml of urine was collected from each subject 
at 0700 hours in the morning into plain bottle 
and immediately taken to the laboratory for 
analysis of urine testosterone. 
 
Testosterone Assay 
Urine testosterone was determined by enzyme 
immunoassay method, using kits (catalog no. 
2095Z) purchased from Diagnostic 




The urinary testosterone concentration (Fig.1) 
in the control (non-cigarette smokers) was 
4.35±0.52 ng/ml, while the concentration was 




































Fig.1: Urine testosterone (ng/ml) in the control (non-
cigarette smokers) and cigarette smokers. Different 




Our study has shown that cigarette smoking 
decrease urinary excretion of testosterone. 
Various reasons have been adduced for the 
low level of plasma testosterone in cigarette 
smokers. It has been suggested that the low 
level of testosterone in cigarette smokers is 
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due to increased activity of liver 6-β-
hydroxylase in cigarette smokers
11
. The 
enzyme is known to increase the metabolism 
of testosterone. In vitro studies indicate that 
nicotine inhibits LH-stimulated 
steroidogenesis in isolated mouse Leydig 
cells5. 
  
High nicotine cigarette smoking may stimulate 
rapid release of prolactin by increasing 
endogenous opiods
12
, which in turn may 
inhibit dopamine release
13
. Yet, endogenous 
opoid peptides also inhibit release of 
hypothalamic luteinising hormone releasing 
hormone (LHRH), which regulates LH release 
from pituitary14. A cigarette smoking-related 
increase in endogenous opoid peptides might 
predict a decrease, rather than an increase in 
LH. 
  
In the previous studies, cigarette smoking has 
been observed to result into increased prolactin 
levels
8,9,15,16
. Similarly, intravenous infusion of 
nicotine has been associated with increased 
prolactin secretion10. Research results have 
reported that pathological hypersecretion of 
prolactin in men is associated with 
hypogonadism and/or impotence and this is 
due to the effects of prolactin on the central 
nervous system control of gonadotropin 
release and sexual behaviour17,18. Prolactin 
may also have direct effects on the 
steroidogenic and gametogenic functions of 
human testis because its receptors (PRL-Rs) 
are localised in the human Leydig cells, 
spermatocytes and spermatids, and in the 
epithelium of the epididymis, vas deferens, 
prostate, and seminal vesicles19. Luteinising 
hormone (LH) stimulates the Leydig cells to 
secrete testosterone and the quantity of 
testosterone secreted increases approximately 
in direct proportion to the amount of LH 
available20. Therefore, by reducing 
gonadotropin secretion, nicotine and cigarette 
smoking could reduce testosterone production. 
  
Our study showed that urinary testosterone 
was lower in cigarette smokers compared to 
the non-cigarette smokers (Fig.1) in subjects 
that are age-matched and of similar body mass 
index (Table 1). This agrees with previous 
studies8,15,16. Though there are many chemicals 
in cigarette smoke, we contend that nicotine, a 
major constituent of tobacco, could be 
responsible for the observed reduced 
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